Indaba Capital Management, L.P.

Name: Indaba Capital Management, L.P. 13F holdings, Q2 2024
Creator: Indaba Capital Management, L.P.
Published: 2024-08-14

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q1 2024

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Indaba Capital Management, L.P. reported 3 stock positions worth $92.0 million. Its top holding was Equity Commonwealth (EQC) at 56.9% of the portfolio, followed by ON24 (ONTF, 27.7%) and Blackline (BL, 15.4%). Compared with Q1 2024, it opened 2 new positions and sold out of 2. The biggest buy was a new position in Equity Commonwealth (EQC) and the biggest sale an exit from Snap One (SNPO).

Most Recent 13F: Q2 2026
Location: SAN FRANCISCO, CA
CIK: 0001524362
Portfolio Value: $92.0M (Q2 2024)
SEC Filing: 0001011438-24-000459 ↗ filed Aug 14, 2024

Holdings Value

Holdings 3 stocks · $92.0M


EQC Equity Commonwealth	56.93%	2,700,000	$52.4M	New
ONTF ON24 Inc.	27.70%	4,240,256	$25.5M	No change
BL Blackline Inc.	15.38%	292,000	$14.1M	New

Other holdings (4): bonds, preferreds, convertibles and warrants · $62.9M (not counted above)

Security	Class	Shares / Principal	Value	Change
BANDWIDTH INC (BAND 0.5 04/01/28)	NOTE 0.500% 4/0 · principal	49,250,000	$37.0M	Reduce -6.2%
XOMETRY INC (XMTR 1 02/01/27)	NOTE 1.000% 2/0 · principal	17,750,000	$13.4M	New
ACCELERATE DIAGNOSTICS (AXDX 5 12/15/26)	NOTE 5.000%12/1 · principal	24,083,901	$11.6M	Add +3.4%
ESPERION THERAPEUTICS (ESPR 4 11/15/25)	NOTE 4.000%11/1 · principal	1,000,000	$926K	New

Total filed on the 13F, all lines: $154.9M.

Portfolio Sells Q1 2024 → Q2 2024


SNPO Snap One Holdings Corp.	Sold out	0.00%	−34.79
LAB Standard Biotools Inc.	Sold out	0.00%	−25.90

Portfolio Buys Q1 2024 → Q2 2024


EQC Equity Commonwealth	New	56.93%	+56.93
BL Blackline Inc.	New	15.38%	+15.38

Notes & Other Activity Q1 2024 → Q2 2024


BANDWIDTH INC (BAND 0.5 04/01/28)	NOTE 0.500% 4/0 · principal	Reduce -6.2%	49,250,000	$37.0M
STANDARD BIOTOOLS INC (LAB 5.25 12/01/24)	NOTE 5.250%12/0 · principal	Sold out	23,190,000	$25.7Mbefore exit
XOMETRY INC (XMTR 1 02/01/27)	NOTE 1.000% 2/0 · principal	New	17,750,000	$13.4M
ACCELERATE DIAGNOSTICS (AXDX 5 12/15/26)	NOTE 5.000%12/1 · principal	Add +3.4%	24,083,901	$11.6M
ESPERION THERAPEUTICS (ESPR 4 11/15/25)	NOTE 4.000%11/1 · principal	New	1,000,000	$926K
HOLLEY INC	*W EXP 11/30/202	Sold out	669,159	$234Kbefore exit

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

Quarter	Positions	13F Reported Value	Top Holdings
Q2 2026	0	$0
Q1 2026	0	$0
Q4 2025	1	$33.8M	ONTF
Q3 2025	2	$25.4M	ONTF, ELME
Q2 2025	6	$46.2M	ONTF, BLKB, BATRK, ESPR, EMBC
Q1 2025	7	$59.9M	ONTF, EQC, BLKB, ESPR, BATRK
Q4 2024	4	$91.2M	OBDE, ONTF, EQC, ESPR
Q3 2024	2	$119.5M	EQC, ONTF
Q2 2024	3	$92.0M	EQC, ONTF, BL
Q1 2024	3	$77.0M	ONTF, SNPO, LAB